M. Hofman, G. Kong, O. Neels, P. Eu, E. Hong, R. Hicks
tlooto Summary
Assessment of the management impact of incremental diagnostic information obtained from this technique compared with conventional staging for neuroendocrine tumours and other somatostatin‐receptor expressing tumours.
Abstract
Introduction: Ga‐68 DOTATATE (Ga‐octreotate, GaTate) positron emission tomography (PET)/CT has multiple advantages compared with conventional and In‐111 octreotide imaging for neuroendocrine tumours and other somatostatin‐receptor expressing tumours. This study assesses the management impact of incremental diagnostic information obtained from this technique compared with conventional staging.
Citation format
HOFMAN, M., et al. High management impact of ga‐68 DOTATATE (gatate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours. Journal of Medical Imaging and Radiation Oncology, 2012, 56.